non-small cell lung cancer PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more. T Cell Repertoire Emerging as Potential Predictor in Neoadjuvant Lung Cancer Immunotherapy Premium A Spanish team is hoping it can further validate promising early results using TCR characteristics to predict the success or failure of pre-surgery chemoimmunotherapy. FDA Approves Takeda's Exkivity With Thermo Fisher CDx for EGFR Exon20 Insertion-Positive NSCLC This is the first time the FDA has approved a drug specifically for NSCLC patients who harbor rare EGFR Exon20 insertion mutations. Japanese Health Ministry Clears Thermo Fisher Scientific Oncomine Assay as CDx for Lung Cancer Drug The Oncomine Dx Target Test can now be used to identify patients with RET-fusion positive NSCLC who may be treated with Eli Lilly's selpercatinib. Oncocyte Launches Prospective Registry to Drive DetermaRx Adoption, Improve Coverage Premium Through its real-world evidence registry, the firm hopes to further validate its NSCLC recurrence risk test as a tool for guiding adjuvant treatment. Aug 17, 2021 Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko Jul 16, 2021 FDA Approves Foundation Medicine's Liquid Biopsy Test as CDx for Novartis' Tabrecta in NSCLC Jun 30, 2021 AmoyDx PCR Panel Receives Japanese Approval as CDx for Non-Small Cell Lung Cancer Therapies Jun 14, 2021 Genecast to Evaluate Liquid Biopsy EGFR Mutation Test in Early-Stage Non-Small Cell Lung Cancer Jun 8, 2021 ASCO Studies Highlight Systemic, Racial Inequities in Lung Cancer Biomarker Testing Premium May 28, 2021 FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen May 21, 2021 FDA Approves Janssen's Rybrevant, Guardant360 CDx for EGFR Exon 20-Mutated NSCLC May 11, 2021 Lucence Launches US Validation Study for Liquid Biopsy in Lung Cancer Apr 19, 2021 Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market Premium Apr 19, 2021 Amgen, NeoGenomics Partner to Expand Biomarker Testing Access in NSCLC Mar 2, 2021 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience for up to $695M Feb 23, 2021 Lung Cancer Organizations to Study Epidemiologic, Genomic Causes in Young Patients Feb 23, 2021 Biocept, Protean BioDiagnostics Team up to Study EGFR Assay in Lung Cancer Feb 11, 2021 UCLA Researchers Look to Validate Saliva as Sample Type for Lung Cancer Molecular Diagnostics Premium Feb 8, 2021 Sophia Genetics, Spanish Lung Cancer Group Team up to Predict Lung Cancer Treatment Response Jan 27, 2021 Spectrum Solutions, UCLA Partner to Study Saliva-Based Early-Stage Lung Cancer Detection Jan 19, 2021 OncoHost Raises $8 Million in Series B Funding Round Jan 11, 2021 Resolution Bioscience, Mirati Therapeutics Sign Companion Diagnostic Agreement Dec 23, 2020 Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China Dec 17, 2020 Stanford Team Develops Mathematical Model of ctDNA Shedding to Predict Lung Cancer Tumor Size Premium Load More Breaking News Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications Sick Infants Profiled with WGS See Better Diagnosis, More Care Changes UC Santa Cruz Center for Live Cell Genomics Wins $13.5M NIH Grant Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating Alternative Genetic Counseling Approach Leads to Higher Patient Satisfaction, Study Suggests The Scan Highly Similar Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News. Gain of Oversight According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research. Lasker for mRNA Vaccine Work The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.